Escola de Veterinária e Zootecnia, Universidade Federal de Goiás, Goiânia, Goiás, Brazil.
Universidade Brasil, Descalvado, São Paulo, Brazil.
Vet Parasitol Reg Stud Reports. 2024 Sep;54:101090. doi: 10.1016/j.vprsr.2024.101090. Epub 2024 Jul 27.
Trypanosoma vivax infections are endemic in Africa, where they provoke trypanosomosis against which some local taurine breeds are tolerant and are thus named trypanotolerant. In Latin America, T. vivax was imported in 1919, since when it has been responsible for periodic outbreaks of the disease. This study assessed whether a South American taurine breed resilient to several parasitic and infectious diseases (Curraleiro Pé-Duro-CPD) can meet trypanotolerant criteria (control parasite proliferation, prevent anemia, survive without treatment, and maintain productivity). Three groups were established, each consisting of six animals (Group 1: CPD-infected; Group 2: Holstein/Gyr-infected; Group 3: Holstein/Gyr-uninfected, negative control). Groups 1 and 2 were infected with T. vivax on Day 0 and evaluated until day 532. Throughout the experimental period, parasitological (Woo and Brener), molecular (cPCR), serological (enzyme-linked immunosorbent assay - ELISA, indirect fluorescent antibody test - IFAT, immunochromatographic assay - IA), and clinical (hemogram, fever, weight loss) aspects were evaluated. During the acute phase of the disease, T. vivax was initially detected in Holstein/Gyr. Notably, the CPD animals restored their packed cell volume (PCV) values to the normal range 74 days after inoculations. In the chronic phase, two of the six CPD animals were positive by cPCR until D + 522 following immunosuppression with dexamethasone. Regarding serological aspects, the two CPD animals had positive tests until D + 532. The absence of T. vivax in blood during the chronic phase did not correspond to "self-cure". Holstein/Gyr animals exhibited fever on more evaluation days than CPD animals. Both breeds experienced weight loss, with Holstein/Gyr animals losing significantly more weight. On D + 25, the Holstein/Gyr group required treatment. During the 532 days, none of the CPD animals required treatment, even after being sensitized with dexamethasone. Animals from Group 3 tested negative for T. vivax throughout the experiment. This study demonstrated that CPD cattle fulfill the mentioned trypanotolerant criteria.
恰加斯病在非洲流行,当地一些牛品种对此具有耐受性,因此被称为耐恰加斯病。在拉丁美洲,1919 年引入了布氏锥虫 vivax,自此,它一直周期性地引发该病。本研究评估了一种对多种寄生虫和传染病具有抵抗力的南美牛品种(库拉雷罗佩杜罗- CPD)是否符合耐恰加斯病标准(控制寄生虫增殖、预防贫血、不治疗而存活以及保持生产力)。建立了三组,每组 6 只动物(第 1 组:CPD 感染;第 2 组:荷斯坦/吉尔感染;第 3 组:荷斯坦/吉尔未感染,阴性对照)。第 1 组和第 2 组于第 0 天感染布氏锥虫 vivax,并评估至第 532 天。在整个实验期间,评估了寄生虫学(Woo 和 Brener)、分子学(cPCR)、血清学(酶联免疫吸附试验 - ELISA、间接荧光抗体试验 - IFAT、免疫层析试验 - IA)和临床(血象、发热、体重减轻)方面。在疾病的急性期,最初在荷斯坦/吉尔牛中检测到布氏锥虫 vivax。值得注意的是,CPD 动物在接种后 74 天恢复了其红细胞压积(PCV)值至正常范围。在慢性期,用地塞米松免疫抑制后,6 只 CPD 动物中有 2 只直到 D+522 时 cPCR 检测为阳性。在血清学方面,2 只 CPD 动物直到 D+532 时仍呈阳性。慢性期血液中没有布氏锥虫 vivax并不意味着“自愈”。荷斯坦/吉尔动物比 CPD 动物在更多的评估日发热。两种品种都经历了体重减轻,荷斯坦/吉尔动物的体重减轻更为明显。在 D+25 天,荷斯坦/吉尔组需要治疗。在 532 天的时间里,即使在用地塞米松致敏后,CPD 动物也不需要治疗。整个实验过程中,第 3 组的动物均未检测到布氏锥虫 vivax。本研究表明,CPD 牛符合上述耐恰加斯病标准。